FDA Inspection 1116972 — LifeServe Blood Center

LifeServe Blood Center — FEI 3000209837

The FDA completed an inspection of LifeServe Blood Center on January 16, 2020 in Urbandale, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 16, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Urbandale, IA (United States)